Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 18 01 2022
accepted: 22 05 2022
pubmed: 9 6 2022
medline: 5 10 2022
entrez: 8 6 2022
Statut: ppublish

Résumé

To correlate somatostatin receptor (SSTR) and proliferative activity profile (SSTR2, SSTR5, Ki-67) at immunohistochemistry (IHC) with SSTR-PET/CT imaging features in a retrospective series of lung neuroendocrine tumors (NET). Proliferative activity by Ki-67 and Among 551 patients who underwent SSTR-PET/CT with Definitive diagnosis consisted of 26 typical carcinoids-G1 and six atypical carcinoids-G2. Positive SSTR2-IHC was found in 62.5% of samples while SSTR5-IHC positivity was 19.4%. A correlation between SSTR2-IHC and SSTR-PET/CT was found in 24/32 cases (75.0%, p = 0.003): 20 were concordantly positive, 4 concordantly negative. For positive IHC, 100% concordance with SSTR-PET/CT (both positive) was observed, while for negative IHC concordance (both negative) was 33.3%. In 8 cases, IHC was negative while SSTR-PET/CT was positive, even though with low-grade uptake in all but one. A significant correlation between SUV This retrospective study showed an overall good agreement between SSTR2-IHC and tumor uptake at SSTR-PET/CT in lung NETs. SSTR-PET/CT SUV

Identifiants

pubmed: 35674739
doi: 10.1007/s00259-022-05848-z
pii: 10.1007/s00259-022-05848-z
pmc: PMC9525360
doi:

Substances chimiques

Gallium Radioisotopes 0
Ki-67 Antigen 0
Organometallic Compounds 0
Receptors, Somatostatin 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Somatostatin 51110-01-1

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4182-4193

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82
pubmed: 26219870
Front Endocrinol (Lausanne). 2021 Apr 27;12:669484
pubmed: 33986731
J Thorac Oncol. 2020 Oct;15(10):1577-1598
pubmed: 32663527
Chest. 2001 Jun;119(6):1647-51
pubmed: 11399686
J Nucl Med. 2021 Oct;62(10):1323-1329
pubmed: 34301785
Tumour Biol. 2014 Sep;35(9):8369-77
pubmed: 24850179
Endocr Pathol. 2004 Winter;15(4):275-91
pubmed: 15681851
Eur J Endocrinol. 2004 Apr;150(4):565-77
pubmed: 15080788
J Nucl Med. 2010 Mar;51(3):353-9
pubmed: 20150249
Eur J Cancer. 2021 Mar;146:56-73
pubmed: 33588146
Anticancer Res. 2013 Oct;33(10):4219-28
pubmed: 24122985
Ann Oncol. 2010 Mar;21(3):548-555
pubmed: 19759190
Clin Nucl Med. 2015 Mar;40(3):e183-9
pubmed: 25608152
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):48-52
pubmed: 18807033
Medicine (Baltimore). 2019 Mar;98(10):e14769
pubmed: 30855482
Virchows Arch. 2001 Dec;439(6):787-97
pubmed: 11787852
Eur J Nucl Med. 2000 Mar;27(3):273-82
pubmed: 10774879
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Mod Pathol. 2007 Nov;20(11):1172-82
pubmed: 17873898
J Nucl Med. 2017 Sep;58(Suppl 2):54S-60S
pubmed: 28864613
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1659-68
pubmed: 21626438
Gastroenterology. 1994 Apr;106(4):951-9
pubmed: 8144000
Front Med (Lausanne). 2020 Jan 29;6:336
pubmed: 32118000
Lung Cancer. 2020 Dec;150:70-75
pubmed: 33075738
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):569-80
pubmed: 22223169
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2083-2093
pubmed: 30657933
Radiographics. 2015 Mar-Apr;35(2):500-16
pubmed: 25763733
Neuroendocrinology. 2017 Mar 30;105(3):212-244
pubmed: 28355596
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571

Auteurs

Vittoria Rufini (V)

Section of Nuclear Medicine, University Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy. Vittoria.Rufini@unicatt.it.
Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Vittoria.Rufini@unicatt.it.
ENETS Center of Excellence for the Diagnosis and Cure of Neuroendocrine Tumors, Rome, Italy. Vittoria.Rufini@unicatt.it.

Margherita Lorusso (M)

ENETS Center of Excellence for the Diagnosis and Cure of Neuroendocrine Tumors, Rome, Italy.
PET/CT Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Frediano Inzani (F)

ENETS Center of Excellence for the Diagnosis and Cure of Neuroendocrine Tumors, Rome, Italy.
Unit of Pathology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Tina Pasciuto (T)

Research Core Facility Data Collection G-STeP, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Elizabeth Katherine Anna Triumbari (EKA)

Section of Nuclear Medicine, University Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.

Lucia Rosalba Grillo (LR)

Pathology Unit, San Camillo-Forlanini Hospitals, Rome, Italy.

Filippo Locco (F)

Section of Thoracic Surgery, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Unit of Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Stefano Margaritora (S)

Section of Thoracic Surgery, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Unit of Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Edoardo Pescarmona (E)

Pathology Unit, 'Regina Elena' National Cancer Institute IRCCS, Rome, Italy.

Guido Rindi (G)

ENETS Center of Excellence for the Diagnosis and Cure of Neuroendocrine Tumors, Rome, Italy.
Unit of Pathology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Section of Pathology, Department of Woman and Child Health and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH